These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 1798965
1. Effect of chlorobutanol and DDAVP on whole blood aggregation/clotting. Stewart MW, Gordon PA. Thromb Res; 1991 Dec 15; 64(6):757-62. PubMed ID: 1798965 [No Abstract] [Full Text] [Related]
2. Is the pro-adhesive activity of plasma von Willebrand factor counteracted by a physiological inhibitor of platelet adhesiveness? Porta M, Cagliero E, Kohner EM. Clin Sci (Lond); 1982 Feb 15; 62(2):239-42. PubMed ID: 6797774 [Abstract] [Full Text] [Related]
3. Availability of endothelial von Willebrand factor and platelet function in diabetic patients infused with a vasopressin analogue. Porta M. Diabetologia; 1982 Nov 15; 23(5):452-5. PubMed ID: 6816652 [Abstract] [Full Text] [Related]
4. Lack of effect of 1-desamino-8-D-arginine vasopressin on direct adhesion of platelets to collagen. Ghosh S, Rao AK. Thromb Res; 1993 Jun 01; 70(5):417-22. PubMed ID: 7690994 [Abstract] [Full Text] [Related]
5. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease. Holmberg L, Nilsson IM, Borge L, Gunnarsson M, Sjörin E. N Engl J Med; 1983 Oct 06; 309(14):816-21. PubMed ID: 6412139 [Abstract] [Full Text] [Related]
6. The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects. Colucci G, Stutz M, Rochat S, Conte T, Pavicic M, Reusser M, Giabbani E, Huynh A, Thürlemann C, Keller P, Alberio L. Blood; 2014 Mar 20; 123(12):1905-16. PubMed ID: 24443440 [Abstract] [Full Text] [Related]
10. Platelet aggregation induced by DDAVP in platelet-type von Willebrand's disease. Takahashi H, Nagayama R, Hattori A, Shibata A. N Engl J Med; 1984 Mar 15; 310(11):722-3. PubMed ID: 6608051 [No Abstract] [Full Text] [Related]
11. Properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) infusion in normal subjects. Takahashi H, Itoh M, Kobayashi I, Sakuragawa N, Shibata A. Tohoku J Exp Med; 1980 Oct 15; 132(2):133-40. PubMed ID: 6777902 [Abstract] [Full Text] [Related]
12. Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction. Rose SS, Faiz A, Miller CH, Saidi P, Philipp CS. Haemophilia; 2008 May 15; 14(3):571-8. PubMed ID: 18312366 [Abstract] [Full Text] [Related]
15. Pre-treatment of porcine pulmonary xenograft with desmopressin: a novel strategy to attenuate platelet activation and systemic intravascular coagulation in an ex-vivo model of swine-to-human pulmonary xenotransplantation. Kim YT, Lee HJ, Lee SW, Kim JY, Wi HC, Park SJ, Bae SJ, Kang HJ. Xenotransplantation; 2008 Feb 15; 15(1):27-35. PubMed ID: 18333911 [Abstract] [Full Text] [Related]
16. [Shortening of acetylsalicylic acid-prolonged bleeding time by means of desmopressin]. Beck KH, Bleckmann U, Mohr P, Kretschmer V, Huss B. Beitr Infusionsther Transfusionsmed; 1994 Feb 15; 32():437-9. PubMed ID: 9480140 [Abstract] [Full Text] [Related]
19. Bleeding time prolongation with streptokinase and its reduction with 1-desamino-8-D-arginine vasopressin. Johnstone MT, Andrews T, Ware JA, Rudd MA, George D, Weinstein M, Loscalzo J. Circulation; 1990 Dec 15; 82(6):2142-51. PubMed ID: 2242538 [Abstract] [Full Text] [Related]
20. Effect of venous occlusion and DDAVP injection on platelet aggregation and platelet cyclic AMP. Egberg N. Thromb Res; 1990 Dec 15; 19(1-2):263-5. PubMed ID: 6255627 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]